Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Implementation of a Cardio Oncology Protocol in Uruguay

Pía Oldan, MD, Andreina Gomez, MD, Gabriel Parma, MD, Cecilia Guillermo, MD, Lilián Díaz, MD, Matilde Boada, MD MSc

Blood (2019) 134 (Supplement_1): 5888.

https://doi.org/10.1182/blood-2019-127068

Published: 2019

Journal Articles

Apache II and Sofa Scores Predict Mortality in Hematologic Malignancies Patients at Intensive Care Unit Admission

Ana Carolina Oliver, MD, Adriana Peixoto, MD, Sabrina Ranero, MD, Rodrigo Anturiano, MD, Cecilia Guillermo, MD, Lilián Díaz, MD

Blood (2017) 130 (Supplement 1): 4677.

https://doi.org/10.1182/blood.V130.Suppl_1.4677.4677

Published: 2017

Journal Articles

Febrile Neutropenia Outcome in Hemato-Oncological Patients after the Implementation of an Adapted Therapeutic Protocol at a University Hospital in Uruguay

Sofia Grille, MD PhD, Boada Matilde, MD, Regina Guadagna, MD, Maria Noel Spangenber, MD, Felipe Lemos, MD, Mariana Stevenazzi, MD, Lilian Diaz, MD, Cecilia Guillermo, MD

Blood (2015) 126 (23): 4471.

https://doi.org/10.1182/blood.V126.23.4471.4471

Published: 2015

Journal Articles

Outcomes and Prognostic Factors in Critically Ill Patients with Hematologic Malignancies Admitted in an Intensive Care Unit: A Single Center Experience. Hospital De Clínicas, Montevideo, Uruguay

Carolina Oliver, MD, Adriana Peixoto, MD, Cecilia Guillermo, MD, Juan Zunino, MD, Mariana Stevenazzi, MD, Alberto Biestro, MD, Lilian Diaz, MD

Blood (2014) 124 (21): 6017.

https://doi.org/10.1182/blood.V124.21.6017.6017

Published: 2014

Journal Articles

99m. Tc-Rituximab as Radiotracer For Molecular Imaging In Non Hodgkin Lymphoma

Ximena Camacho, MSc, Agustina Banchero, MD, Maria Fernanda García, MSc, Marcelo Fernández, BSc, Natalia Oddone, BSc, María Moreno, PhD, Cecilia Guillermo, MD, Juan Pablo Gambini, MD, PhD, Pablo Cabral, MSc, PhD, Eloísa Riva, MD

Blood (2013) 122 (21): 3026.

https://doi.org/10.1182/blood.V122.21.3026.3026

Published: 2013

Journal Articles

Comparison CHOP Like Vs Rituximab (R) + CHOP in Non Hodgkin Lymphomas (NHL): Nine Years Uruguayan University Hospital Experience

Carolina Oliver, MD, Paula Martinez, MD, Cecilia Guillermo, MD, Lilián Díaz, MD

Blood (2011) 118 (21): 4976.

https://doi.org/10.1182/blood.V118.21.4976.4976

Published: 2011

Journal Articles

Autologous Stem Cell Transplantation for NHL: 16 Years Follow- up

Cecilia Guillermo, MD, Judith Lipschutz, MD, Juan Zunino, MD, Laura Topolansky, MD, Alejandra Rocca, MD, Mariana Stevenazzi, MD, Andrea Diaz, MD, Susana Perdomo, MD, Ana Perdomo, MD, Graciela M Lavagna, Hugo Isaurralde, MD, Lilian Diaz, MD, Martha Nese, MD

Blood (2011) 118 (21): 4520.

https://doi.org/10.1182/blood.V118.21.4520.4520

Published: 2011

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Non Hodgkin Lymphomas (NHL).

Martha C. Nese, MD, Cecilia Guillermo, MD, Hugo Isaurralde, MD, Lilian Diaz, MD, Laura Topolansky, MD, Juan Zunino, MD, Susana Perdomo, MD, Ana Perdomo, MD, Graciela Lavagna, MD, Andrea Diaz, MD, Mariana Stevenazzi, MD, Alberto Baubeta, MD

Blood (2006) 108 (11): 5430.

https://doi.org/10.1182/blood.V108.11.5430.5430

Published: 2006

NARROW

Implementation of a Cardio Oncology Protocol in Uruguay

Apache II and Sofa Scores Predict Mortality in Hematologic Malignancies Patients at Intensive Care Unit Admission

Febrile Neutropenia Outcome in Hemato-Oncological Patients after the Implementation of an Adapted Therapeutic Protocol at a University Hospital in Uruguay

Outcomes and Prognostic Factors in Critically Ill Patients with Hematologic Malignancies Admitted in an Intensive Care Unit: A Single Center Experience. Hospital De Clínicas, Montevideo, Uruguay

99m. Tc-Rituximab as Radiotracer For Molecular Imaging In Non Hodgkin Lymphoma

Comparison CHOP Like Vs Rituximab (R) + CHOP in Non Hodgkin Lymphomas (NHL): Nine Years Uruguayan University Hospital Experience

Autologous Stem Cell Transplantation for NHL: 16 Years Follow- up

Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Non Hodgkin Lymphomas (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only